• Twitter
  • Jobs
ProCURE oncology
  • HOME
  • ABOUT US
  • RESEARCH GROUP
    • Molleví’s Lab
    • Antolin’s Lab
    • Alemany’s & Piulats’s lab
    • Martínez-Balibrea’s Lab
    • Aytes’s Lab
    • Belver’s Lab
    • Pujana’s Lab
    • Menendez’s Lab
    • Sureda’s & Farre’s Lab
    • Casanovas’s Lab
    • Viñals’s lab
  • INNOVATION
  • NEWS
  • CONTACT
  • Menu Menu

News

Prenatal diagnosis of congenital heart disease using four-dimensional spatio-temporal image correlation (STIC) telemedicine via an Internet link: a pilot study

14 de December de 2004
Ultrasound Obstet Gynecol. 2005 Jan;25(1):25-31. doi: 10.1002/uog.1796.ABSTRACTOBJECTIVE:…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2004-12-14 11:00:002004-12-14 11:00:00Prenatal diagnosis of congenital heart disease using four-dimensional spatio-temporal image correlation (STIC) telemedicine via an Internet link: a pilot study

P38SAPK2 phosphorylates cyclin D3 at Thr-283 and targets it for proteasomal degradation

25 de August de 2004
Oncogene. 2004 Sep 30;23(45):7537-44. doi: 10.1038/sj.onc.1208040.ABSTRACTCyclin…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2004-08-25 10:00:002004-08-25 10:00:00P38SAPK2 phosphorylates cyclin D3 at Thr-283 and targets it for proteasomal degradation

Myogenin protein stability is decreased by BMP-2 through a mechanism implicating Id1

24 de August de 2004
J Biol Chem. 2004 Oct 29;279(44):45766-72. doi: 10.1074/jbc.M408059200.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2004-08-24 10:00:002004-08-24 10:00:00Myogenin protein stability is decreased by BMP-2 through a mechanism implicating Id1

BMP-2 decreases Mash1 stability by increasing Id1 expression

20 de August de 2004
EMBO J. 2004 Sep 1;23(17):3527-37. doi: 10.1038/sj.emboj.7600360.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2004-08-20 10:00:002004-08-20 10:00:00BMP-2 decreases Mash1 stability by increasing Id1 expression

Antiproliferative effects of ZD0473 (AMD473) in combination with 5-fluorouracil or SN38 in human colorectal cancer cell lines

5 de August de 2004
Invest New Drugs. 2004 Nov;22(4):399-409. doi: 10.1023/B:DRUG.0000036682.99818.71.ABSTRACTPURPOSE:…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2004-08-05 10:00:002004-08-05 10:00:00Antiproliferative effects of ZD0473 (AMD473) in combination with 5-fluorouracil or SN38 in human colorectal cancer cell lines

cAMP inhibits TGFbeta1-induced in vitro angiogenesis

1 de July de 2004
FEBS Lett. 2004 Jul 2;569(1-3):105-11. doi: 10.1016/j.febslet.2004.05.058.ABSTRACTTransforming…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2004-07-01 10:00:002004-07-01 10:00:00cAMP inhibits TGFbeta1-induced in vitro angiogenesis

A novel muscle DNA-binding activity in the GLUT1 promoter

31 de March de 2004
Cell Mol Life Sci. 2004 Mar;61(6):709-20. doi: 10.1007/s00018-003-3395-y.ABSTRACTGLUT1…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2004-03-31 11:00:002004-03-31 11:00:00A novel muscle DNA-binding activity in the GLUT1 promoter

Allogeneic transplantation of hematopoietic stem cells after nonmyeloablative conditioning for Hodgkin’s disease: indications and results

19 de February de 2004
Semin Oncol. 2004 Feb;31(1):27-32. doi: 10.1053/j.seminoncol.2003.10.018.ABSTRACTA…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2004-02-19 11:00:002004-02-19 11:00:00Allogeneic transplantation of hematopoietic stem cells after nonmyeloablative conditioning for Hodgkin’s disease: indications and results

Active stress kinase p38 enhances and perpetuates abnormal tau phosphorylation and deposition in Pick’s disease

23 de December de 2003
Acta Neuropathol. 2004 Mar;107(3):185-9. doi: 10.1007/s00401-003-0793-z.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2003-12-23 11:00:002003-12-23 11:00:00Active stress kinase p38 enhances and perpetuates abnormal tau phosphorylation and deposition in Pick’s disease

A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation

6 de December de 2003
Brain Pathol. 2003 Oct;13(4):440-51. doi: 10.1111/j.1750-3639.2003.tb00475.x.ABSTRACTImmunostaining…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2003-12-06 11:00:002003-12-06 11:00:00A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation

Identification of a novel proliferation-dependent C-rich element that mediates inhibition of the rat GLUT1 promoter

3 de December de 2003
Gene. 2003 Dec 11;322:47-55. doi: 10.1016/j.gene.2003.09.003.ABSTRACTExpression…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2003-12-03 11:00:002003-12-03 11:00:00Identification of a novel proliferation-dependent C-rich element that mediates inhibition of the rat GLUT1 promoter

Weekly regimen of irinotecan/docetaxel in previously treated non-small cell lung cancer patients and correlation with uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphism

31 de October de 2003
Invest New Drugs. 2003 Nov;21(4):435-43. doi: 10.1023/a:1026251202137.ABSTRACTPURPOSE:…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2003-10-31 11:00:002003-10-31 11:00:00Weekly regimen of irinotecan/docetaxel in previously treated non-small cell lung cancer patients and correlation with uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphism
Page 85 of 88«‹8384858687›»

Filter by categories

  • Alemany’s & Piulats’s lab (135)
  • Antolin's lab (36)
  • Aytes's Lab (25)
  • Belver's Lab (25)
  • Casanovas's Lab (77)
  • Martínez-Balibrea's Lab (43)
  • Menendez's Lab (121)
  • Molleví's Lab (35)
  • Pujana's Lab (112)
  • Sin categoría (12)
  • Sureda's & Farre's Lab (319)
  • Viñals's lab (113)

Twitter

Tweets by ProcureICO
Program Against Cancer Therapeutic Resistance

CONTACT US

Campus IDIBELL
(L’Hospitalet del Llobregat)
Hospital Duran i Reynals, Gran Via 199,
L’Hospitalet del Llobregat,
Barcelona 08908
Tel. +34 93 260 7952

Campus IGTP-IJC
(Badalona)
Campus Can Ruti – IGTP – Building Muntanya,
Rd. Can Ruti, Camí de les escoles s/n,
Badalona, Barcelona 08916
Tel. +34 93 554 3069

Campus IDIBGI
(Girona)
Parc Hospitalari Martí i Julià de Salt, Dr. Castany s/n,
Salt, Girona 17190
Tel. +34 872 987 087

© Copyright - Edisenius
  • Privacy Policy
  • Cookie Policy
  • Legal Notice
Scroll to top
Manage cookie consent
To offer the best experiences, we use technologies such as cookies to store and/or access device information. Consent to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Failure to consent, or withdrawal of consent, may adversely affect certain features and functions.
Functional Always active
Storage or technical access is strictly necessary for the legitimate purpose of allowing the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. Storage or technical access that is used exclusively for anonymous statistical purposes. Without a requirement, voluntary compliance by your Internet service provider, or additional records from a third party, information stored or retrieved solely for this purpose cannot be used to identify you.
Marketing
Storage or technical access is necessary to create user profiles to send advertising, or to track the user on a website or several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
See preferences
{title} {title} {title}